Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eishi Baba

Showing results (121-130 of 189) with videos related to

Pageof 19
Sort By:
Blood|January 21, 2012
CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cellsHiroaki Niiro, Siamak Jabbarzadeh-Tabrizi, Yoshikane Kikushige, et al.
Anticancer Research|January 1, 2015
Reduced dose of salvage-line regorafenib monotherapy for metastatic colorectal cancer in JapanGen Hirano, Akitaka Makiyama, Chinatsu Makiyama, et al.
Medicine|December 17, 2017
Metastatic esophageal cancer presenting as shock by injury of vagus nerve mimicking baroreceptor reflex: A case reportKenji Tsuchihashi, Tomoyasu Yoshihiro, Tomomi Aikawa, et al.
Anticancer Research|January 10, 2014
Pemetrexed combined with platinum-based chemotherapy for advanced malignant peritoneal mesothelioma: retrospective analysis of six casesMichitaka Nakano, Hitoshi Kusaba, Akitaka Makiyama, et al.
Cancer Science|March 22, 2023
RHAMM marks proliferative subpopulation of human colorectal cancer stem cellsMichitaka Nakano, Ryosuke Taguchi, Yoshikane Kikushige, et al.
British Journal of Cancer|March 24, 2020
OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibodyHirofumi Ohmura, Kyoko Yamaguchi, Fumiyasu Hanamura, et al.
Cancer Letters|February 12, 2022
Macrophages are primed to transdifferentiate into fibroblasts in malignant ascites and pleural effusionsMamoru Ito, Michitaka Nakano, Hiroshi Ariyama, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2023
Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactionsKoki Uehara, Kenro Tanoue, Kyoko Yamaguchi, et al.
Medicine|June 21, 2018
A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapyHozumi Kumagai, Hitoshi Kusaba, Takeharu Yamanaka, et al.
Japanese Journal of Clinical Oncology|November 8, 2025
Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumorsAya Takigawa, Kenji Tsuchihashi, Kenta Nio, et al.
Pageof 19

Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Blood|January 21, 2012
CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cellsHiroaki Niiro, Siamak Jabbarzadeh-Tabrizi, Yoshikane Kikushige, et al.
Anticancer Research|January 1, 2015
Reduced dose of salvage-line regorafenib monotherapy for metastatic colorectal cancer in JapanGen Hirano, Akitaka Makiyama, Chinatsu Makiyama, et al.
Medicine|December 17, 2017
Metastatic esophageal cancer presenting as shock by injury of vagus nerve mimicking baroreceptor reflex: A case reportKenji Tsuchihashi, Tomoyasu Yoshihiro, Tomomi Aikawa, et al.
Anticancer Research|January 10, 2014
Pemetrexed combined with platinum-based chemotherapy for advanced malignant peritoneal mesothelioma: retrospective analysis of six casesMichitaka Nakano, Hitoshi Kusaba, Akitaka Makiyama, et al.
Cancer Science|March 22, 2023
RHAMM marks proliferative subpopulation of human colorectal cancer stem cellsMichitaka Nakano, Ryosuke Taguchi, Yoshikane Kikushige, et al.
British Journal of Cancer|March 24, 2020
OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibodyHirofumi Ohmura, Kyoko Yamaguchi, Fumiyasu Hanamura, et al.
Cancer Letters|February 12, 2022
Macrophages are primed to transdifferentiate into fibroblasts in malignant ascites and pleural effusionsMamoru Ito, Michitaka Nakano, Hiroshi Ariyama, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2023
Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactionsKoki Uehara, Kenro Tanoue, Kyoko Yamaguchi, et al.
Medicine|June 21, 2018
A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapyHozumi Kumagai, Hitoshi Kusaba, Takeharu Yamanaka, et al.
Japanese Journal of Clinical Oncology|November 8, 2025
Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumorsAya Takigawa, Kenji Tsuchihashi, Kenta Nio, et al.
Pageof 19